Repligen
RGEN
458 hedge funds and large institutions have $8.86B invested in Repligen in 2021 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 176 increasing their positions, 155 reducing their positions, and 57 closing their positions.
26% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 57
14% more repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 155
2% more funds holding
Funds holding: 449 → 458 (+9)
1% more capital invested
Capital invested by funds: $8.76B → $8.86B (+$98.7M)
1.26% less ownership
Funds ownership: 84.75% → 83.49% (-1.3%)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
38% less call options, than puts
Call options by funds: $32.1M | Put options by funds: $52.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$148M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.5M |
| 3 |
BlackRock
New York
|
+$48.2M |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
+$42.1M |
| 5 |
FAM
Fred Alger Management
New York
|
+$34.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$110M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$58.6M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$52.8M |
| 4 |
Renaissance Technologies
New York
|
-$42M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$38.9M |
RGEN Hedge Fund Activity: Q1 2021 in Review
458 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2021, worth a combined $8.86B — up 1.1% from $8.76B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new RGEN positions and 57 closed out — a net gain of 15 holders — while 176 added to existing stakes and 155 trimmed.
The largest buyer was Brown Capital Management, opening a new position worth an estimated $148M. The largest seller was Marshall Wace, cutting an estimated $110M.
- 458 institutional investors held Repligen (RGEN) as of Q1 2021, up from 449 in Q4 2020.
- Funds reported $8.86B of Repligen stock for Q1 2021, up 1.1% quarter-over-quarter.
- 72 funds opened new Repligen positions in Q1 2021 and 57 closed out, a net change of +15 holders.
- The largest Repligen buyer in Q1 2021 was Brown Capital Management, an estimated $148M added.
- The largest Repligen seller in Q1 2021 was Marshall Wace, an estimated $110M sold.
Based on aggregated 13F filings for Q1 2021.